Similar articles

• Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Expression of P53 product in the different ploidy classes.

  Leonardi E, Cristofori A, Caffo O, Dalla Palma P. Leonardi E, et al. Anal Cell Pathol. 1997;15(1):31-45. doi: 10.1155/1997/345949. Anal Cell Pathol. 1997. PMID: 9373711 Free PMC article.
• Expression of Bcl-2 in human breast cancer: correlation between hormone receptor status, p53 protein accumulation and DNA strand breaks associated with apoptosis.

  Hori M, Nogami T, Itabashi M, Yoshimi F, Ono H, Koizumi S. Hori M, et al. Pathol Int. 1997 Nov;47(11):757-62. doi: 10.1111/j.1440-1827.1997.tb04453.x. Pathol Int. 1997. PMID: 9413034
• Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.

  Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S. Linjawi A, et al. J Am Coll Surg. 2004 Jan;198(1):83-90. doi: 10.1016/j.jamcollsurg.2003.08.008. J Am Coll Surg. 2004. PMID: 14698315
• Triple-negative breast cancer: current state of the art.

  Rastelli F, Biancanelli S, Falzetta A, Martignetti A, Casi C, Bascioni R, Giustini L, Crispino S. Rastelli F, et al. Tumori. 2010 Nov-Dec;96(6):875-88. Tumori. 2010. PMID: 21388048 Review.
• Prognostic factors in breast carcinoma.

  Weidner N. Weidner N. Curr Opin Obstet Gynecol. 1995 Feb;7(1):4-9. Curr Opin Obstet Gynecol. 1995. PMID: 7742514 Review.